The Board of Directors of Hangzhou Alltest Biotech Co., Ltd. has authorized a buyback plan on July 22, 2022.
Hangzhou Alltest Biotech Co., Ltd.
Equities
688606
CNE1000053G6
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
47.5 CNY | -1.90% |
|
-2.96% | -30.76% |
Apr. 29 | China, HK stocks rise, led by property shares | RE |
Apr. 26 | Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-30.76% | 507M | |
-10.54% | 11.41B | |
-12.48% | 7.4B | |
+31.15% | 5.64B | |
0.00% | 5.33B | |
-18.68% | 3.7B | |
+7.43% | 2.58B | |
-64.53% | 2.38B | |
+27.01% | 2.2B | |
-11.35% | 2.2B |
- Stock Market
- Equities
- 688606 Stock
- News Hangzhou Alltest Biotech Co., Ltd.
- Hangzhou Alltest Biotech Co., Ltd. authorizes a Buyback Plan.